|
 |
| home > ebr > spring 2002 > donation of organs and tissues - new legislation in finland on the prerequisites for medical research |
|
|
 PUBLICATIONS |
European BioPharmaceutical Review
|
| The protection of and right to human organs, tissues and genomics in medical research is an increasingly discussed topic and it gives rise not only to reforms of legislation but also to ethical debate. The ratification of the Convention of Human Rights and Biomedicine (1) in 1997 required some changes to the then existing legislation in Finland, but at the same time it was considered necessary to reform the legislation on human organs and tissues in medical research as a whole. In addition, other international conventions, such as the United Nations Convention on Civil and Political Rights (2), put pressure on the national legislation of human organs and tissues in medical research.The most recent considerable reform in Finland in relation to biosciences law was the introduction of the Act on Medical Use of Human Organs and Tissues in 2001. The new legislation will certainly influence the future of the medical use of human organs and tissues in Finland, both from a contractual and a practical point of view. |
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
By Rainer Hilli, Partner, and Liisa Laurila, Lawyer, at Roschier Holmberg, Attorneys Ltd
Rainer Hilli is a Partner at Roschier Holmberg and is responsible for the company's technology, media and competition group, specialising mainly in matters relating to copyright, patents, trademarks, designs, computer law, telecommunications law, media law, market law and the life sciences.
Rainer's experience includes multi-jurisdictional IP litigation and IP-driven acquisitions. He is a frequent speaker and writer of articles in the field of intellectual property.
Liisa Laurila, MSc (Econ), LLM, works as a Lawyer for Roschier Holmberg in the technology, media and competition practice group. Liisa is a member of the firm's pharmaceutical and biosciences specialist team.
She advises on copyright and trademarks as well as on general corporate matters. Liisa specialises in data protection and life sciences law, and her working languages are Finnish, Swedish and English.
|
|
|
|
|
|
 |
Industry Events |
 |
EuroBiopartnering 2008
7-9 October 2008, Paris, France
EuroBiOpartnering
2008 gives you the unique opportunity to meet the relevant decision makers and
opinion leaders from the international biotech community and offers you 3 days
of partnering opportunities including one-to-one meetings, company presentations
and further networking activities…
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Announces Plans to Implement XcelodoseTM Technology in the Production of Early Stage Clinical Trial Materials
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today plans to implement Xcelodose technology at its formulations development facility, ApiCross Drug Delivery Technologies. Xcelodose technology is a powder micro-dosing system developed by Meridica. This technology offers a unique powder dispensing system for small-scale capsule filling and ultimately assists in conserving valuable research material as well as reducing various Preformulation activities.
More info >> |
|
 |
